Nephros, Inc. (NEPH)

Market Cap	39.64M -31.9%
Revenue (ttm)	20.72M +24.2%
Net Income	1.74M +30.8%
EPS	0.16 +34.3%
Shares Out	10.86M
PE Ratio	22.81
Forward PE	19.21
Dividend	n/a
Ex-Dividend Date	n/a

Volume	45,994
Open	3.450
Previous Close	3.510
Day's Range	3.390 - 3.650
52-Week Range	2.663 - 6.420
Beta	1.64
Analysts	Buy
Price Target	6.25 (+71.23%)
Est. Earnings	Nov 5, 2026

About NEPH

Nephros, Inc., a commercial-stage company, develops and sells water filtration solutions for medical and commercial applications in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in foodservice and hospitality, and other healthcare facilities. The company also manufactures and sells water filters that ...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• IPO Date: Sep 21, 2004
• Employees: 36
• Stock Exchange: Nasdaq
• Ticker Symbol: NEPH
• Website: https://www.nephros.com

Financial Performance

In 2025, Nephros's revenue was $18.79 million, an increase of 32.67% compared to the previous year's $14.16 million. Earnings were $1.19 million, an increase of 1513.51%.

Analyst Summary

According to 3 analysts, the average rating for NEPH stock is "Buy." The 12-month stock price target is $6.25, which is an increase of 71.23% from the latest price.

Price Target

$6.25

(71.23% upside)

Analyst Consensus: Buy

Data Sources: S&P Global Market Intelligence, CBOE, and more

Fundamental and historical data is provided by S&P Global Market Intelligence. Real-time stock price data is provided by CBOE and 15-minute delayed consolidated tape pricing data is provided by Nasdaq UTP.

Last checked:

Oct 17, 2026

Data Sources Report a data error